Candel Therapeutics Inc (NASDAQ:CADL) concluded the trading at $7.98 on Wednesday, May 01, with a rise of 13.19% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $7.05. Considering stock’s 52-week price range provides that CADL hit a high price of $11.40 and saw its price falling to a low level of $0.66 during that period. Over a period of past 1-month, stock came adding 372.19% in its value.
With its current market valuation of $234.21 million. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.91 for current year with estimates of that growing to 0 in next year.
In contrast, when we review CADL stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 100% Buy for it.
Digging deeper we become aware of the PEG ratio of the CADL stock which is currently positioned at 0. It further provides that stock’s current price level is 36.60% away from its 20-day simple moving average and is 141.13% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 74.64 while volatility remained at 13.38% over the past week which changes to 32.85% when measuring it over the past month. Beta is valued at -0.93, while measure of average true range or ATR is currently at 0.89.
Having a second look at Candel Therapeutics Inc (NASDAQ:CADL) provides that stock’s average daily trading volume for 3 months was 5.33 million. Number of outstanding shares of the stock stood at 29.21 million.
The percentage of outstanding shares held by the insiders is 46.65% while it is 5.81% for the institutional holders. Addition of 442.86% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
